Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1987 Oct;147(4):461.

Short-Contact Anthralin Therapy for Psoriasis

Heidi E Fleischmann
PMCID: PMC1025917  PMID: 18750341

Full text

PDF

Page 461

461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton R. E., Andre P., Lowe N. J., Whitefield M. Anthralin: historical and current perspectives. J Am Acad Dermatol. 1983 Aug;9(2):173–192. doi: 10.1016/s0190-9622(83)70125-8. [DOI] [PubMed] [Google Scholar]
  2. Gorsulowsky D. C., Voorhees J. J., Ellis C. N. Anthralin therapy for psoriasis. A new look at an old compound. Arch Dermatol. 1985 Dec;121(12):1509–1511. [PubMed] [Google Scholar]
  3. Lowe N. J., Ashton R. E., Koudsi H., Verschoore M., Schaefer H. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. J Am Acad Dermatol. 1984 Jan;10(1):69–72. doi: 10.1016/s0190-9622(84)80046-8. [DOI] [PubMed] [Google Scholar]
  4. Schaefer H., Farber E. M., Goldberg L., Schalla W. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Br J Dermatol. 1980 May;102(5):571–573. doi: 10.1111/j.1365-2133.1980.tb07657.x. [DOI] [PubMed] [Google Scholar]
  5. Schaefer H. Short-contact therapy. Arch Dermatol. 1985 Dec;121(12):1505–1509. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES